---
title: "Lecture 3: Cox model when PH assumption is violated"
toc: true
toc-depth: 3
---


```{r, echo=FALSE}
knitr::opts_chunk$set(
  message = FALSE,
  warning = FALSE
)
```

## Learning Objectives

::: callout-note
By the end of this lecture, you should be able to:

- Recognise when the **proportional hazards (PH) assumption** is violated
- Understand different strategies to handle non-PH:
  - Stratified Cox model
  - Time-varying effects
  - Extended Cox with time-varying covariates
- Understand when a **joint model** is needed

:::



## Reminder: Proportional Hazards Assumption

The Cox model assumes that **hazard ratios are constant over time**.

This means that if one group has higher risk than another at the beginning,
it has the same *relative* risk later in follow-up.

::: {.callout-note}
If this assumption does not hold, the estimated hazard ratio from a standard Cox model
may be misleading.
:::


## What If Proportional Hazards Does Not Hold?

There are several approaches when PH is violated:

1. **Stratified Cox model:** allow baseline hazards to differ by group.
2. **Include time-varying effect:** model changing effects over time, include interaction between covariate and time (e.g. $ùë•√óùë°$). 
3. **Use extended Cox model:** allow a covariate‚Äôs value itself to change over time.



## Stratified Cox model

When the proportional hazards (PH) assumption is violated for a categorical variable, one option is a **stratified Cox model**.

A stratified Cox model can be written as:

$$
h_s(t \mid X) = h_{0s}(t)\,\exp(\beta_1 X_1 + \beta_2 X_2 + \cdots)
$$

where:

- $s$ is the stratum (e.g. donor type)
- $h_{0s}(t)$ is the **baseline hazard for stratum $s$**
- $X_1, X_2, \ldots$ are other covariates

 **What does stratification mean?**  

If we stratify on a variable (e.g. **donor type**):

- We **do not estimate a single hazard ratio** for the stratifying variable anymore  
  (we are not saying ‚Äúliving vs deceased = HR 0.7‚Äù)
- The stratifying variable is used only to **define strata**
- Each stratum is allowed to have a **different baseline risk trajectory** over time

In words:

> Patients with living donors and patients with deceased donors are allowed to have completely different baseline hazards over time.

**What is still estimated?**   

We still estimate the effects of other covariates (e.g. donor age, recipient sex, eGFR at transplant), assuming those effects are **proportional within each stratum**.

::: {.callout-note}
Stratification is useful when a variable strongly affects baseline risk but does not satisfy the PH assumption.
:::


Stratification can be thought of as:

> **‚ÄúParallel Cox models with different baseline hazards, but the same slopes for the other covariates.‚Äù**

That is, each group has its own baseline risk over time, but covariate effects are assumed to be the same across groups.


::: {.callout-tip}
### When to Use It

‚úÖ  **When to use stratification**
Use stratification when:

- The proportional hazards (PH) violation is mainly driven by **one categorical variable** (e.g. donor type)
- You still want to **adjust for this variable**
- But you do **not need its hazard ratio** as a main result

In this case, the variable is used to define strata rather than being estimated as a coefficient.



‚ùå **When not to use stratification**
Do **not** use stratification when:

- The stratifying variable is your **primary exposure of interest**
- You need to report a **hazard ratio comparing groups**

Because once you stratify on a variable (e.g. donor type), you **no longer obtain a single hazard ratio** comparing those groups.
:::



## Example: Handling Non-Proportional Hazards Using Stratified Cox Model

We are interested in whether time to graft failure after kidney transplantation differs by donor type (living vs deceased), after adjusting for important clinical factors.


We begin by fitting a standard Cox proportional hazards model, then check the PH assumption.
If the PH assumption is violated for any categorical covariate in the model, we refit the model using stratification by that covariate.

```{r, message=FALSE, warning=FALSE}
library(survival)

stratified_kidney_data<-read.csv("stratified_kidney_data.CSV")

cox_standard <- coxph(
  Surv(time, status) ~ donor_type +
    donor_age +
    recipient_gender +
    egfr_baseline,
  data = stratified_kidney_data
)

#summary(cox_standard)

#check the PH assumption first 
ph_test <- cox.zph(cox_standard)
ph_test
plot(ph_test)
```

::: {.callout-note}
A small p-value indicates evidence against the proportional hazards assumption.
:::

**Interpretation of PH diagnostics**  

The proportional hazards assumption is violated for donor type.  
Other covariates do not show strong evidence of violation.  
The global test is significant, indicating overall non-proportionality.  
This suggests that the effect of donor type on graft failure risk changes over time, making the standard Cox model inappropriate.  


**Stratified Cox model**  

To address this violation, we fit a stratified Cox model, stratifying on donor type.

```{r, message=FALSE, warning=FALSE}
library(survival)
cox_strat <- coxph(
Surv(time, status) ~ donor_age + recipient_gender + egfr_baseline +
strata(donor_type),
data = stratified_kidney_data
)

summary(cox_strat)

```


::: {.callout-note}
- We no longer estimate a hazard ratio for donor type.

- Donor type is now used only to define separate baseline hazards.

- Effects of other covariates are assumed proportional within each stratum.
:::



::: {.callout-tip}
### Interpretation 

Within each donor type (living and deceased), we interpret covariate effects as follows:

‚úÖ Donor age  

HR ‚âà 1.01 (95% CI: 0.997‚Äì1.03, P-value=0.14), Not statistically significant.  
Within each donor type, donor age shows no strong association with graft failure.

‚úÖ Recipient gender (male)

HR ‚âà 1.58 (95% CI: 1.16‚Äì2.13, P-value=0.003), Statistically significant.
Male recipients have about 58% higher hazard of graft failure compared to females
This comparison is within donor type, adjusting for donor age and eGFR.

‚úÖ eGFR at transplant

HR ‚âà 0.99 (95% CI: 0.97‚Äì1.00, P-value=0.033), Statistically significant.
Each 1-unit increase in baseline eGFR is associated with about 1‚Äì2% lower hazard of graft failure, within each donor type.
To improve interpretability, we can express the effect per **10-unit increase** in eGFR:

$$
HR_{10\text{-unit}} = 0.99^{10} \approx 0.90
$$

**Interpretation:**  
Within each donor type, a 10-unit higher eGFR at the time of transplant is associated with approximately a **10% lower hazard of graft failure**, after adjusting for donor age and recipient gender.
:::

::: {.callout-tip}


### What about donor type?

Stratifying by donor type allows each group to have its own baseline hazard curve, effectively removing the need to assume a constant hazard ratio over time.  

The curves demonstrate that living and deceased donor grafts follow different survival trajectories ‚Äî exactly what we expect when the PH assumption is violated.

:::

```{r, message=FALSE, warning=FALSE}

# cox_strat is the stratified cox model we fitted in previous chunk 
sf_strat <- survfit(cox_strat)

# Convert survfit to a tidy data frame for ggplot
sf_df <- data.frame(
  time  = sf_strat$time,
  surv  = sf_strat$surv,
  lower = sf_strat$lower,
  upper = sf_strat$upper,
  strata = rep(names(sf_strat$strata), sf_strat$strata)
)

# Clean up the stratum labels from "donor_type=deceased" ‚Üí "deceased"
sf_df$strata <- sub("donor_type=", "", sf_df$strata)

library(ggplot2)

stratified_cox_plot<-ggplot(sf_df, aes(x = time, y = surv, colour = strata)) +
  geom_step(linewidth = 1.2) +
  geom_ribbon(aes(ymin = lower, ymax = upper, fill = strata),
              alpha = 0.15, linewidth = 0) +
  scale_colour_manual(values = c("deceased" = "#365abd",  # deep blue
                                 "living"   = "#c0397e"))+ # magenta/rose

  scale_fill_manual(values = c("deceased" = "#365abd",
                               "living"   = "#c0397e")) +
  labs(
    title = "Stratified Cox Model\nDifferent Baseline Hazards by Donor Type",
    x = "Time since transplant (years)",
    y = "Predicted survival probability",
    colour = "Donor type",
    fill   = "Donor type"
  ) +
  coord_cartesian(ylim = c(0.4, 1)) +
  theme_grey(base_size = 14) +
  theme(
    plot.title       = element_text(face = "bold", hjust = 0.5),
    legend.position  = "bottom",
    legend.title     = element_text(face = "bold")
  )

stratified_cox_plot

```




::: {.callout-warning}
### Why Ignoring PH Violations Can Be Misleading

If we ignore the violation of the proportional hazards (PH) assumption and proceed with a standard Cox model, we may obtain a single hazard ratio that does **not accurately reflect how risk changes over time**.

This can lead to misleading conclusions, as the estimated effect represents an average over follow-up rather than the true time-varying relationship.

This is illustrated in the plot below, where the separation between groups is clearly **not constant over time**.

:::


```{r, message=FALSE, warning=FALSE}

#data preparation for plot 

new_deceased <- data.frame(
  donor_type = factor("deceased", levels = levels(as.factor(stratified_kidney_data$donor_type))),
  donor_age = mean(stratified_kidney_data$donor_age, na.rm = TRUE),
  recipient_gender = factor("female", levels = levels(as.factor(stratified_kidney_data$recipient_gender))),
  egfr_baseline = mean(stratified_kidney_data$egfr_baseline, na.rm = TRUE)
)

new_living <- data.frame(
  donor_type = factor("living", levels = levels(as.factor(stratified_kidney_data$donor_type))),
  donor_age = mean(stratified_kidney_data$donor_age, na.rm = TRUE),
  recipient_gender = factor("female", levels = levels(as.factor(stratified_kidney_data$recipient_gender))),
  egfr_baseline = mean(stratified_kidney_data$egfr_baseline, na.rm = TRUE)
)





sf_deceased <- survfit(cox_standard, newdata = new_deceased)
sf_living   <- survfit(cox_standard, newdata = new_living)


df_dec <- data.frame(
  time       = sf_deceased$time,
  surv       = sf_deceased$surv,
  lower      = sf_deceased$lower,
  upper      = sf_deceased$upper,
  donor_type = "Deceased donor"
)

df_liv <- data.frame(
  time       = sf_living$time,
  surv       = sf_living$surv,
  lower      = sf_living$lower,
  upper      = sf_living$upper,
  donor_type = "Living donor"
)


df_ph <- rbind(df_dec, df_liv)




standard_cox_plot<-ggplot(df_ph, aes(x = time, y = surv, colour = donor_type, fill = donor_type)) +
  # CI ribbon
  geom_ribbon(aes(ymin = lower, ymax = upper),
              alpha = 0.2,
              colour = NA,
              show.legend = FALSE) +
  # Step survival curve
  geom_step(linewidth = 1.2) +
  
  # Manual colours for consistency across slides
  scale_colour_manual(
    values = c("Deceased donor" = "#365abd",   # blue
               "Living donor"   = "#c0397e")   # magenta/rose
  ) +
  scale_fill_manual(
    values = c("Deceased donor" = "#365abd",
               "Living donor"   = "#c0397e")
  ) +
  
  # Axis labels and title
  labs(
    title = "Standard Cox PH Model\nAssumes Constant Effect of Donor Type",
    x = "Time since transplant (years)",
    y = "Predicted survival probability",
    colour = "Donor type"
  ) +
  
  # y-axis from 0.4 to 1.0
  coord_cartesian(ylim = c(0.4, 1.0)) +
  
  # Use grey theme with gridlines
  theme_grey(base_size = 14) +
  theme(
    plot.title       = element_text(face = "bold", hjust = 0.5),
    legend.position  = "bottom",
    legend.title     = element_text(face = "bold")
  )




 
library(gridExtra)
library(ggplot2)

# Reduce title size for each plot
standard_cox_plot_small <- standard_cox_plot +
  theme(plot.title = element_text(size = 10))

stratified_cox_plot_small <- stratified_cox_plot +
  theme(plot.title = element_text(size = 10))

# Arrange side by side
grid.arrange(
  standard_cox_plot_small,
  stratified_cox_plot_small,
  ncol = 2
)

```


## Including Time-Varying Effects

When the proportional hazards (PH) assumption is violated, **stratification is not the only solution**.

In some settings, we still want to:

- **Keep the covariate in the model**
- **Obtain an explicit effect estimate**
- **Allow the effect to change over time**

This leads to a **time-varying coefficient Cox model**.


 **When to Use Time-Varying Effects**  

Use a time-varying effect when:

- The PH assumption is violated for a variable (e.g. **donor type**)
- The variable is scientifically important
- You believe the **effect itself changes over time**

For example:

- Early after transplant, **living donors may be protective**
- Later, that advantage may **diminish or reverse**

**Model Idea**  

In the **standard Cox model**:

$$
h(t \mid X) = h_0(t)\exp(\beta_1 X_1 + \beta_2 X_2 + \cdots)
$$

the coefficients ($\beta$) are assumed to be **constant over time**, which leads to the **proportional hazards (PH) assumption**.



If a covariate‚Äôs effect **changes over time**, we can allow its coefficient to depend on time:

$$
h(t \mid X) = h_0(t)\exp\left(\beta_1(t) X_1 + \beta_2 X_2 + \cdots\right)
$$

This allows the **hazard ratio for $X_1$ to vary with time**.

:::{.callout-note}

### Intuition

Instead of assuming the two groups keep the same relative risk forever,  
we allow the **risk difference between groups to change over time**.

:::

::: {.callout-tip}
### When to Use It

- You detect a **proportional hazards (PH) violation** for a variable (e.g. **donor type**) but you **still want an explicit effect estimate**, rather than stratifying it away.
- For example:
  - **Early after transplant**, living donors may be **protective**
  - **Later**, that advantage may **diminish or reverse**

:::




## Example: Time-Varying Effect of Donor Type

We return to the kidney transplant example:

- **Outcome:** time to graft failure  
- **Exposure:** donor type (living vs deceased)  
- **Covariates:** donor age, recipient gender, baseline eGFR  

Previously, we showed that **donor type violates the PH assumption**.

We introduce an **interaction between the covariate and time**, most commonly:

- **donor type √ó log(time)**  
- **donor type √ó time**

This allows the model to estimate **how the effect changes with time**.

The Cox model becomes:

$$
h(t) = h_0(t)\exp\left[\beta_1 \,\text{donor\_type} + \beta_2 \left(\text{donor\_type} \times \log(t)\right) + \cdots \right]
$$

Where:

- $\beta_1$ represents the **baseline (early) effect** of donor type  
- $\beta_2$ represents **how that effect changes over time**



```{r, message=FALSE, warning=FALSE}
library(survival)

kidney_violate <- read.csv("stratified_kidney_data.csv")

kidney_violate$donor_live <- ifelse(kidney_violate$donor_type == "living", 1, 0)

cox_timevary <- coxph(
  Surv(time, status) ~ donor_live +
    donor_age +
    recipient_gender +
    egfr_baseline +
    tt(donor_live),
  data = kidney_violate,
  tt = function(x, t, ...) {
    x * log(t + 0.01)
  }
)

summary(cox_timevary)
```

::: {.callout-note}

- donor_live represents the baseline effect  

- tt(donor_live) allows the effect to change with time  

- $\log(t)$ captures gradual, nonlinear change  
:::



**How to Interpret the Model**

<table style="width:100%; table-layout: fixed;">
<colgroup>
  <col style="width:12%">
  <col style="width:10%">
  <col style="width:12%">
  <col style="width:10%">
  <col style="width:56%">
</colgroup>
<thead>
<tr>
  <th>Variable</th>
  <th>HR<br>(exp(coef))</th>
  <th>95% CI</th>
  <th>p-value</th>
  <th>Interpretation</th>
</tr>
</thead>
<tbody>
<tr>
  <td><strong>donor_live</strong></td>
  <td>0.50</td>
  <td>0.25 ‚Äì 1.01</td>
  <td>0.054 (‚âà 0.05)</td>
  <td>
    At the <strong>start of follow-up</strong> (when $\log(t) \approx 0$),
    recipients of a <strong>living donor</strong> kidney have about
    <strong>50% lower hazard</strong> of graft failure compared to
    deceased-donor recipients.
  </td>
</tr>

<tr>
  <td><strong>tt(donor_live)</strong></td>
  <td>3.53</td>
  <td>2.15 ‚Äì 5.79</td>
  <td>&lt; 0.001 ***</td>
  <td>
    The <strong>effect of living donor changes significantly over time</strong>.
    The hazard ratio increases by roughly a factor of <strong>3.5</strong>
    for each unit increase in $\log(t)$.
    In other words, the early advantage from living donors
    <strong>diminishes as time goes on</strong>.
  </td>
</tr>

<tr>
  <td><strong>donor_age</strong></td>
  <td>1.01</td>
  <td>1.00 ‚Äì 1.03</td>
  <td>0.14</td>
  <td>
    Older donor age shows a <strong>small, non-significant trend</strong>
    toward higher hazard of graft failure.
  </td>
</tr>

<tr>
  <td><strong>recipient_gender (male)</strong></td>
  <td>1.58</td>
  <td>1.16 ‚Äì 2.13</td>
  <td>0.003 **</td>
  <td>
    Male recipients have about <strong>58% higher hazard</strong>
    of graft failure than females, adjusting for other factors.
  </td>
</tr>

<tr>
  <td><strong>egfr_baseline</strong></td>
  <td>0.99</td>
  <td>0.97 ‚Äì 1.00</td>
  <td>0.032 *</td>
  <td>
    Each 1-unit higher baseline eGFR reduces the hazard of graft failure
    by roughly <strong>1‚Äì2%</strong>, indicating better baseline kidney
    function is <strong>protective</strong>.
  </td>
</tr>
</tbody>
</table>





**Visualising the Time-Varying Hazard Ratio**

```{r, message=FALSE, warning=FALSE}
library(ggplot2)

b <- coef(cox_timevary)
v <- vcov(cox_timevary)

beta1 <- b["donor_live"]
beta2 <- b["tt(donor_live)"]

var_beta1 <- v["donor_live", "donor_live"]
var_beta2 <- v["tt(donor_live)", "tt(donor_live)"]
cov_b1b2  <- v["donor_live", "tt(donor_live)"]

t_seq <- seq(0.5, 8, by = 0.1)
log_t <- log(t_seq + 0.01)

lp <- beta1 + beta2 * log_t
var_lp <- var_beta1 + (log_t^2) * var_beta2 + 2 * log_t * cov_b1b2
se_lp <- sqrt(var_lp)

hr_df <- data.frame(
  time  = t_seq,
  HR    = exp(lp),
  lower = exp(lp - 1.96 * se_lp),
  upper = exp(lp + 1.96 * se_lp)
)

ggplot(hr_df, aes(x = time, y = HR)) +
  geom_ribbon(aes(ymin = lower, ymax = upper),
              alpha = 0.2, fill = "#c75b87") +
  geom_line(linewidth = 1.2, colour = "#c75b87") +
  geom_hline(yintercept = 1,
             linetype = "dashed",
             colour = "grey50") +
  labs(
    title = "Time-varying effect of donor type",
    subtitle = "Hazard ratio: living vs deceased donor",
    x = "Time since transplant (years)",
    y = "Hazard ratio"
  ) +
  theme_grey(base_size = 14) +
  theme(
    plot.title = element_text(face = "bold", hjust = 0.5),
    plot.subtitle = element_text(hjust = 0.5),
    panel.grid.minor = element_blank()
  )
```





::: {.callout-tip}

### Interpretation

Early follow-up: HR < 1 ‚Üí protective effect of living donors

Later follow-up: HR increases and may exceed 1

Uncertainty increases at longer follow-up due to fewer events


The HR steadily increases and crosses 1 after roughly 1‚Äì2 years, indicating the early survival advantage of living donors diminishes.  

By 5‚Äì8 years, the HR > 2‚Äì3, suggesting higher hazard among living-donor grafts in the later period.  

The confidence band widens with time because there are fewer events and greater uncertainty at longer follow-up. 

:::

## Extended Cox Model

Before introducing the **extended Cox model**, it is important to distinguish between
**time-fixed covariates** and **time-varying covariates**.


::: {.callout-note}

### Time-Fixed vs Time-Varying Covariates

**Time-Fixed Covariates:** 

A **time-fixed covariate** is measured once (usually at baseline) and assumed to remain
constant throughout follow-up.

Examples:

- **Donor type**
- **Sex**
- **Age at transplant**
- **Baseline eGFR**


**Time-Varying Covariates:**

A **time-varying covariate** is a variable whose **value itself changes over time**.

Examples:

- **eGFR measured repeatedly after transplant**
- **Blood pressure**
- **Medication use**
- **Biomarkers measured at follow-up visits**

:::


::: {.callout-warning}
Time-varying covariates are different from **time-varying effects**.

- **Time-varying effect:** the *coefficient* changes with time  
- **Time-varying covariate:** the *value of the covariate* changes with time
:::



**Why Time-Varying Covariates Can Cause PH Violation**  


If we treat a changing covariate as fixed at baseline:

- We ignore important changes in a patient‚Äôs risk profile
- The model may show **non-proportional hazards**
- Early and late risks are incorrectly averaged

For example:

- eGFR at transplant may be similar between patients
- Over time, eGFR may decline at different rates
- Current kidney function is more relevant than baseline eGFR


**Extended Cox Model (Time-Varying Covariates)**  

The **extended Cox model** explicitly allows covariate values to change over time.


::: {.callout-note}
### Intuition

- Split each subject‚Äôs follow-up into **time intervals**
- Update the covariate value within each interval
- Model the hazard using the **current covariate value**

**Why this addresses PH violation:**  

- PH was violated partly because ‚Äúrisk profile changes over time.‚Äù  
- The extended Cox model explicitly updates the covariates over time instead of pretending they‚Äôre frozen at baseline.  
- This is different from stratification and different from adding x √ó time: here the value itself is time-dependent.  
:::


The model is written as:

$$
h(t \mid X(t)) = h_0(t)\exp\left(\beta_1 X_1(t) + \beta_2 X_2 + \cdots\right)
$$




::: {.callout-tip}
### When to Use It

- A predictor **changes over time**
- The **current value** of the predictor matters for risk *right now*
- Treating the variable as baseline-only is unrealistic

Examples:

- ‚ÄúeGFR at year 2 predicts risk between year 2 and 3‚Äù
- ‚ÄúIf eGFR worsens, the risk of graft failure increases after that‚Äù
:::





## Example: Extended Cox Model (Time-Varying Covariates)

This example demonstrates how to fit an **extended Cox model** when a covariate
(e.g. **eGFR**) **changes over time**.

We create a dataset in **start‚Äìstop format**, where each individual contributes
multiple time intervals.

For each interval we record:

- **start:** beginning of the time interval  
- **stop:** end of the time interval  
- **status:** did graft failure occur at `stop`  
- **egfr_current:** eGFR measured at the **start of that interval**

The extended Cox model uses the **current value** of the covariate:

$$
h(t) = h_0(t)\exp\left(\beta_1 \,\text{egfr\_current}(t)
+ \beta_2 \,\text{donor\_type}
+ \cdots \right)
$$

Here:

- **egfr\_current(t)** is updated over time  
- The hazard reflects the patient‚Äôs **current kidney function**, not baseline values

::: {.callout-warning}

### Data Structure: Wide vs Long Format

**Wide (Baseline-Only) Format**

Each subject has **one row**, with multiple eGFR measurements stored in columns.

- `egfr0`, `egfr2`, `egfr4`, `egfr6` represent measurements at fixed times  
- This format is **not suitable** for extended Cox models



**Long (Start‚ÄìStop) Format**

Each subject contributes **multiple rows**, one per interval.

Key columns:

- **id**
- **start**
- **stop**
- **status**
- **egfr_current**
- **baseline covariates** (donor type, age, sex)

This format allows the model to use the **current eGFR** at each time interval.

:::


**Fitting the Extended Cox Model**

```{r, message=FALSE, warning=FALSE}
library(survival)

long_data<-read.csv("egfr_long_data.CSV")

cox_extended <- coxph(
  Surv(start, stop, status) ~
    egfr_current +
    donor_type +
    donor_age +
    recipient_gender,
  data = long_data
)

summary(cox_extended)

```


::: {.callout-tip}
### Interpretation

We interpret the results of the **extended Cox model (time-varying covariates)** as follows:

‚úÖ **Current eGFR**

HR ‚âà 0.92 (95% CI: 0.86‚Äì0.98, P-value = 0.01), **Statistically significant**.  
Each 1 mL/min/1.73 m¬≤ higher **current eGFR** is associated with about an **8% lower instantaneous hazard** of graft failure, holding donor type, donor age, and recipient gender constant.

This means that **the patient‚Äôs current kidney function**, rather than baseline eGFR, is strongly predictive of graft failure risk.

---

‚úÖ **Donor type (living vs deceased)**

HR ‚âà 1.28 (95% CI: 0.24‚Äì6.83, P-value = 0.77), **Not statistically significant**.  
Once **time-updated eGFR** is included in the model, there is **no evidence of a direct effect** of donor type on graft failure.

**Interpretation:**  
The apparent advantage of living donors observed earlier appears to operate **through better kidney function over time**, rather than through an independent direct effect.

---

‚úÖ **Donor age**

HR ‚âà 1.03 (95% CI: 0.97‚Äì1.09, P-value = 0.39), **Not statistically significant**.  
There is no strong evidence that donor age is associated with graft failure once current eGFR and other covariates are accounted for.

---

‚úÖ **Recipient gender (male vs female)**

HR ‚âà 1.36 (95% CI: 0.45‚Äì4.10, P-value = 0.58), **Not statistically significant**.  
After adjusting for time-updated eGFR and other covariates, there is no clear evidence of a gender difference in graft failure risk.

---

**Overall interpretation:**  
The extended Cox model highlights that **time-updated eGFR is the dominant predictor of graft failure**.  
Accounting for changes in kidney function over time substantially alters the interpretation of other covariate effects and provides a more realistic representation of evolving risk.
:::
 















::: {.callout-warning}
The extended Cox model treats time-varying covariates as **external**.

If the covariate is influenced by the underlying disease process
(e.g. declining eGFR because the graft is failing),
this assumption may be violated ‚Äî motivating **joint models**.
:::
